Luteal Phase Progesterone Support in Modified Natural Cycle Frozen Embryo Transfer – RBMO
Reproductive BioMedicine Online (RBMO) shared a post on LinkedIn:
“The results of this Danish study indicate that progesterone luteal phase support (LPS) does not appear to be associated with increased live birth rate (LBR) in modified natural cycle frozen embryo transfer (mNC-FET).
Frederikke Moll Engesgaard and colleagues show that most women do not benefit from LPS in mNC-FET, implicating a need to revise current treatment protocols to avoid unnecessary use of medication associated with both physical discomfort and costs.
They show that some subgroups may benefit from progesterone LPS in mNC-FET; hence, it is advised that progesterone LPS should be considered as an individualized rather than routine treatment.
Published open access, the paper can be read in full for free from issue 53.2 now.”
Title: Luteal phase progesterone support in modified natural cycle frozen embryo transfer: a systematic review and meta-analysis
Authors: Frederikke Moll Engesgaard, Amalie Somuncu Johansen, Marte Saupstad, Nathalie Friis Wang, Anja Pinborg, Kristine Løssl
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 24, 2026, 08:13Ongoing Gaps in Contraceptive Access and Experience – BPAS
-
Jun 24, 2026, 08:01Joint RCOG-BSGE Event on Chronic Pelvic Pain – RCOG
-
Jun 24, 2026, 07:54CFAS 72nd Annual Meeting Opens Registration for Calgary 2025 – CFAS
-
Jun 24, 2026, 07:47Aïda Pujol Masana: Behind Each IVF Cycle – The Precision of the Embryology Lab
-
Jun 24, 2026, 07:39Tom Bourne: Gynaecological Cancer Diagnosis and Rapid Access Clinics Take Focus at IOTA Course
-
Jun 24, 2026, 07:00UK Guidelines for the Medical and Laboratory Procurement and Use of Sperm, Egg and Embryo Donors! – RBMO
-
Jun 24, 2026, 00:02Your C-Section Scar Could Be decreasing Your IVF Baby Dreams – Fertility Plus
-
Jun 23, 2026, 23:53Reem Prince: Marked Unilateral Femoral Shortening Seen at 22 Weeks of Gestation
-
Jun 23, 2026, 23:43Emma Marie Swift: Nearly One-Third of Eligible Women Did Not Recall Aspirin Advice